- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05571254
The Management of Transient Loss of Consciousness and Suspected Syncope in European Emergency Departments (SEED)
The Management of Transient Loss of Consciousness (TLOC) and Suspected Syncope in European Emergency Departments: a Prospective Cohort Study
Study Overview
Detailed Description
Syncope is a common ED problem. The three underlying causes are reflex (simple faint), orthostatic hypotension (blood pressure fall on standing) and cardiac disease (structural heart disease or cardiac dysrhythmia). Diagnosis is difficult and is not apparent in ~50% of patients after assessment. For the first time, European Society of Cardiology (ESC) guidelines incorporating ED management of patients presenting with TLOC, either undifferentiated or thought to be of syncopal origin, have been produced.
However, very little is currently known about the use of diagnostic algorithms and management of this patient group in EDs across Europe. As a result, the application of guidelines and the management of TLOC by European Society of Emergency Medicine (EUSEM) members in different countries and hospitals, cannot yet be recommended for use in settings other than those where they have been successfully validated.
This study aims to describe the prevalence, clinical presentation, current assessment, management strategies and ESC risk categories of patients presenting with TLOC (undifferentiated or thought to be of syncopal origin) to the ED, and will provide data to help identify the gaps in our knowledge and practice, and areas where further research and development work is required to fully implement European Society of Cardiology (ESC) guidelines within European EDs.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Durres, Albania
- Regional Hospital Durres
-
Elbasan, Albania
- Regional Hospital Centre "Xh. Kongoli" Elbasan
-
Sarande, Albania
- Spitali "Petro Nako" Sarandra
-
Shkodra, Albania
- Regional Hospital Shkoder
-
Tirana, Albania
- University Hospital Centre "Mother Theresa" Tirana
-
-
-
-
-
Vienna, Austria
- Allgemeines Krankenhaus der Stadt Wien/ Universitätskliniken
-
Vienna, Austria
- Klinik Donaustadt
-
-
-
-
-
Brugge, Belgium
- AZ Sint Jan Brugge
-
Eeklo, Belgium
- AZ Alma Eeklo
-
Ghent, Belgium
- Ghent University Hospital
-
Lier, Belgium
- Heilig Hartziekenhuis Lier
-
-
-
-
-
Králová, Czechia
- University Hospital Hradec Kralove
-
Praha, Czechia
- University Hospital Kralovske Vinohrady
-
-
-
-
-
Herning, Denmark
- Regionshospitalet Gødstrup
-
Hillerød, Denmark
- Nordsjællands Hospital
-
Randers, Denmark
- Regionshospitalet Randers
-
Roskilde, Denmark
- Sjællands Universitetshospital
-
Vildbjerg, Denmark
- Regionshospitalet Midt
-
-
-
-
-
Helsinki, Finland
- Kanta-Häme Central Hospital
-
-
-
-
-
Besançon, France
- CHU Besançon
-
Caen, France
- CHU Caen
-
Clermont-Ferrand, France
- CHU Clermond-Ferrand
-
Lyon, France
- Medipole
-
Tours, France
- CHU Tours
-
-
-
-
-
Athens, Greece
- University General Hospital Attikon
-
Heraklion, Greece
- General Hospital Venizeleio
-
Thessaloníki, Greece
- AHEPA Univesrity General Hospital of Thessaloniki
-
-
-
-
-
Budapest, Hungary
- Semmelweis University Department of Emergency Medicine
-
-
-
-
-
Bologna, Italy
- ED Azienda Ospedaliera Universitaria di Bologna (Sant'Orsola Hospital)
-
Catania, Italy
- ED Azienda Ospedaliera-universitaria di Catania (San Marco Hospital)
-
Firenze, Italy
- ED Azienda USL Toscana Centro, Firenze (San Giovanni di Dio Hospital)
-
Perugia, Italy
- Azienda Ospedaliera di Perugia (Santa Maria Della Misericordia Hospital)
-
Verona, Italy
- ED Azienda Ospedaliera-Universitaria integrata (Borgo Trento Hospital)
-
-
-
-
-
Birkirkara, Malta
- Mater dei hospital
-
Victoria, Malta
- Gozo General Hospital
-
-
-
-
-
Trondheim, Norway
- St. Olav's University Hospital
-
-
-
-
-
Wrocław, Poland
- Wroclaw University Hospital
-
-
-
-
-
Cluj-Napoca, Romania
- Cluj Napoca County Emergency Clinical Hospital
-
Iaşi, Romania
- Saint Spiridon County Hospital
-
-
-
-
-
Belgrad, Serbia
- Emergency Center Belgrade, Clinical Centre Belgade
-
Niš, Serbia
- Clinical Centre of Nis
-
Zaječar, Serbia
- Emergency Department Zaječar, Health Center Zaječar
-
-
-
-
-
Alicante, Spain
- Hospital Dr. Balmis
-
Barcelona, Spain
- Hospital Universitari de Bellvitge
-
Barcelona, Spain
- Hospital Clinic Barcelona
-
Barcelona, Spain
- Hospital de Terrassa
-
Barcelona, Spain
- Hospital Universitari de Vic
-
-
-
-
-
Ankara, Turkey
- Gazi University Medical Faculty Department of Emergency Medicine
-
Ankara, Turkey
- Medical Science University Ankara Education and Research Hospital Department of Emergency Medicine
-
Karaman, Turkey
- Karamanoglu Mehmetbey University Karaman Education and Research Hospital Department of Emergency Medicine
-
Konya, Turkey
- Necmettin Erbakan University Medical Faculty Department of Emergency Medicine
-
Şanlıurfa, Turkey
- Medical Science University Sanliurfa Mehmet Akif Inan Education and Research Hospital Department of Emergency Medicine
-
-
-
-
-
Coventry, United Kingdom
- University Hospital Coventry & Warwickshire
-
Kirkcaldy, United Kingdom
- Victoria Hospital
-
Livingston, United Kingdom
- St Johns Hospital, Livingston
-
Preston, United Kingdom
- Royal Preston Hospital
-
-
Midlothian
-
Edinburgh, Midlothian, United Kingdom, EH16 4SA
- Royal Infirmary of Edinburgh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult patients (≥18 years old) assessed in the ED with TLOC thought to be of syncopal origin.
Exclusion Criteria:
- Inability to consent
- Patient in custody or prison
- Aged <18 years
- TLOC thought to be due to neurological seizure (e.g., epilepsy/alcohol or drug withdrawal) or trauma
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant age
Time Frame: Admission
|
Participant age
|
Admission
|
|
Participant gender
Time Frame: Admission
|
Participant gender
|
Admission
|
|
Mode of arrival
Time Frame: Admission
|
Mode of arrival
|
Admission
|
|
Referral source
Time Frame: Admission
|
Referral source
|
Admission
|
|
Presence of any European Society of Cardiology (ESC) syncope high-risk history features
Time Frame: Admission
|
Which European Society of Cardiology syncope high-risk history features are present
|
Admission
|
|
ESC high-risk 'past medical history' features
Time Frame: Admission
|
Which European Society of Cardiology syncope high-risk 'past medical history' features are present
|
Admission
|
|
Other medical comorbidities
Time Frame: Admission
|
Other medical comorbidities
|
Admission
|
|
Rockwood Clinical Frailty Scale score
Time Frame: Admission
|
Rockwood Clinical Frailty Scale is a well validated score ranging from 1 (Very Fit) to 9 (Terminally Ill) with defined descriptions for each category.
|
Admission
|
|
ESC high risk 'physical examination' factors
Time Frame: Admission
|
ESC high risk 'physical examination' factors
|
Admission
|
|
Blood pressure (BP) on admission
Time Frame: Admission
|
First Blood pressure (BP) measure in the Emergency Department in mmHg
|
Admission
|
|
Pulse rate on admission
Time Frame: Admission
|
First pulse rate measured in the Emergency Department in beats per minute
|
Admission
|
|
Lying/standing systolic BP difference on admission
Time Frame: Admission
|
First lying/standing systolic BP difference measured in the Emergency Department in mmHg
|
Admission
|
|
Number of participants with abnormal Electrocardiogram (ECG) readings
Time Frame: Admission
|
Number of participants with abnormal ECG readings
|
Admission
|
|
Troponin levels
Time Frame: Admission
|
Troponin levels
|
Admission
|
|
D-dimer levels
Time Frame: Admission
|
D-dimer levels
|
Admission
|
|
Copeptin levels
Time Frame: Admission
|
Copeptin levels
|
Admission
|
|
Natriuretic peptides levels
Time Frame: Admission
|
Natriuretic peptides levels
|
Admission
|
|
ED clinician diagnosis
Time Frame: Admission
|
ED clinician diagnosis - descriptive
|
Admission
|
|
Patient destination
Time Frame: Admission
|
Descriptive options: Admitted to Observation/Clinical Decision Unit/Same Day Emergency Care unit/hospital floor with telemetry monitoring/hospital floor with no telemetry monitoring.
Discharged to outpatient follow up/family doctor/General Practitioner care/home with no follow up
|
Admission
|
|
Reason(s) for admission
Time Frame: Admission
|
Reason(s) for admission
|
Admission
|
|
Whether driving and occupation advice given
Time Frame: Admission
|
Whether driving and occupation advice given
|
Admission
|
|
Status at discharge from hospital
Time Frame: 30 days
|
Status at discharge from hospital
|
30 days
|
|
Length of hospital stay in days
Time Frame: 30 days
|
Length of hospital stay in days
|
30 days
|
|
Hospital discharge diagnosis
Time Frame: 30 days
|
Hospital discharge diagnosis
|
30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Matt Reed, University of Edinburgh
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AC22033
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.